Latest Breaking News On - Healthcare conference presentation - Page 1 : comparemela.com

Zymeworks Stock: A Buy On Key Catalysts, Strong Cash Position (ZYME)

Zymeworks Stock: A Buy On Key Catalysts, Strong Cash Position (ZYME)
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

Ken galbraithJazz pharmaceuticalsGetty imagesAsia pacificHealthcare conference presentation

Soleno Therapeutics And Acadia Pharmaceuticals: Hope For Prader–Willi Families (ACAD)

Soleno Therapeutics And Acadia Pharmaceuticals: Hope For Prader–Willi Families (ACAD)
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

Alpha solenoDoug williamsonAcadia pharmaceuticalsHead of researchFoundation for prader willi researchSoleno therapeuticsPrader willi syndromeHealthcare conference presentationThird quarterSeeking alphaRatings summaryAcadia presentationAcadia callWall streetSeeking alpha analystsSoleno presentation

AngioDynamics Announces FDA 510(k) Clearance of Auryon XL Radial Access Catheter to Treat Peripheral Arterial Disease

225-cm Catheter Length Expands Access Points in Atherectomy Procedures to Help Reduce Access Site Complications and Accelerate Patient Recovery .

United statesCraig walkerAngiodynamicjp morganAnkur lodhaKimberly nelsonAuryon global marketing at angiodynamics incCardiovascular institute of theDrug administrationClinical sciences research journalAmerican heart associationCardiovascular institute of the southAngiodynamics incUnited states foodAuryon atherectomy systemPeripheral arterial diseaseSenior director

Ironwood Pharmaceuticals Maintains FY 2023 Financial Guidance and Announces FY 2024 Financial Guidance

– Expects high-single digit percentage LINZESS® EUTRx prescription demand growth in 2024 – – Expects 2024 adjusted EBITDA of greater than $150 million – .

United statesTom mccourtIronwood pharmaceuticalsIronwood pharmaceuticals incIronwood pharmaceuticals nasdaqExchange commissionHealthcare conferenceFull yearHealthcare conference presentationCommon adverse reactionsPrescribing informationBoxed warningAnnual reportQuarterly reports

Apellis Announces Preliminary Fourth Quarter and Full Year 2023 U S Net Product Revenues

Apellis Announces Preliminary Fourth Quarter and Full Year 2023 U S Net Product Revenues
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesLissa pavlukMeredith kayaCedric francoisExchange commissionAdvisory committee on immunization practicesEuropean unionExchange commission onApellis pharmaceuticals incAnnounces preliminary fourth quarterFull yearOctober injectorHealthcare conference presentationHealthcare conferenceSafety informationRetinal detachments